Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Oncotarget|July 23, 2016
Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8+ T cells directed against tumor-associated antigensAndreas Kirschner, Melanie Thiede, Franziska Blaeschke, et al.
Oncotarget|October 7, 2016
T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blastsJudith Feucht, Simone Kayser, David Gorodezki, et al.
Journal for Immunotherapy of Cancer|September 17, 2020
Leukemia escape in immune desert: intraocular relapse of pediatric pro-B-ALL during systemic control by CD19-CAR T cellsSemjon Willier, Johannes Raedler, Franziska Blaeschke, et al.
Cell Reports|June 2, 2021
Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineeringJennifer R Hamilton, Connor A Tsuchida, David N Nguyen, et al.
Blood|October 23, 2020
CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapySemjon Willier, Paula Rothämel, Maximilian Hastreiter, et al.
Elife|December 31, 2021
Robust T cell activation requires an eIF3-driven burst in T cell receptor translationDasmanthie De Silva, Lucas Ferguson, Grant H Chin, et al.
Leukemia|March 24, 2020
Leukemia-induced dysfunctional TIM-3<sup>+</sup>CD4<sup>+</sup> bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patientsFranziska Blaeschke, Semjon Willier, Dana Stenger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 31, 2021
Protective T cell receptor identification for orthotopic reprogramming of immunity in refractory virus infectionsTanja A Stief, Theresa Kaeuferle, Thomas R Müller, et al.
Molecular Therapy. Methods & Clinical Development|March 26, 2021
Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cellsNicole Cordes, Carolin Kolbe, Dominik Lock, et al.
Blood|June 3, 2020
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CARDana Stenger, Tanja A Stief, Theresa Kaeuferle, et al.
Pageof 4